Company WuXi AppTec Co., Ltd.

Equities

603259

CNE1000031K4

Biotechnology & Medical Research

End-of-day quote Shanghai S.E. 07:00:00 2024-03-27 pm EDT 5-day change 1st Jan Change
47.03 CNY +0.97% Intraday chart for WuXi AppTec Co., Ltd. -5.98% -35.36%

Business Summary

WuXi AppTec Co., Ltd. specializes in providing a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical and biotech industries worldwide to advance discoveries and deliver groundbreaking treatments to patients. Net sales break down by activity as follows:

- laboratory services (60.9%): small molecules discovery services, bioanalytical services, medical devices safety testing services, comprehensive manufacturing and testing services for cell and gene therapies, etc.;

- CMO and CDMO services (31.9%): development of manufacturing processes, production of advanced intermediates and active pharmaceutical ingredients, formulation development and dosage drug product manufacturing, for preclinical and clinical trials, new drug application, and commercial supply of chemical drugs, etc.;

- clinical research services (7.1%): project planning, clinical operation and monitoring and managements of phase I-IV clinical trials, medical device trials, etc.;

- other (0.1%).

Net sales are distributed geographically as follows: China (25.1%), Asia (4.1%), the United States (53.6%), Europe (16%) and other (1.2%) .

Number of employees: 41,116

Sales per Business

CNY in Million2022Weight2023Weight Delta
Chemical
72.3 %
28,850 73.3 % 29,171 72.3 % +1.12%
Test
16.2 %
5,719 14.5 % 6,540 16.2 % +14.36%
Biology
6.3 %
2,475 6.3 % 2,553 6.3 % +3.13%
High-end treatment CTDMO
3.2 %
1,308 3.3 % 1,310 3.2 % +0.12%
Domestic New Drug Research and Development Service
1.8 %
970 2.5 % 726 1.8 % -25.08%
Other Business
0.1 %
34 0.1 % 41 0.1 % +22.12%

Sales per region

CNY in Million2022Weight2023Weight Delta
United States
64.8 %
25,884 65.8 % 26,132 64.8 % +0.96%
China
18.3 %
7,526 19.1 % 7,372 18.3 % -2.05%
Europe
11.6 %
4,432 11.3 % 4,698 11.6 % +6.00%
Other Regions
5.3 %
1,512 3.8 % 2,139 5.3 % +41.46%

Managers

Managers TitleAgeSince
Founder 54 00-11-30
Chief Executive Officer 56 00-11-30
Chief Executive Officer 55 15-11-30
Chief Executive Officer 54 -
Director of Finance/CFO 50 21-12-31
Director of Finance/CFO - -
Director of Finance/CFO 49 21-03-31
Chief Investment Officer 61 06-12-31
Chief Tech/Sci/R&D Officer - 19-04-07
Chief Operating Officer - -

Members of the board

Members of the board TitleAgeSince
Chief Investment Officer 61 06-12-31
Director/Board Member 50 16-03-22
Chief Executive Officer 56 00-11-30
Founder 54 00-11-30
Director/Board Member 55 23-05-30
Chief Executive Officer 54 -
Director/Board Member 53 00-12-31
Chief Executive Officer 55 15-11-30
Director/Board Member 60 99-12-31
Director/Board Member 71 23-05-30

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 387,076,150 0 0 66.64 %
Stock B 1 2,546,239,690 1,954,715,487 ( 76.77 %) 0

Shareholders

NameEquities%Valuation
Qatar Holding LLC
9.489 %
38,198,400 9.489 % 238 M ¥
Qatar Investment Authority (Investment Management)
2.074 %
8,349,600 2.074 % 52 M ¥
BlackRock Fund Advisors
1.923 %
7,741,706 1.923 % 48 M ¥
BlackRock Advisors (UK) Ltd.
1.307 %
5,263,096 1.307 % 33 M ¥
Zhong Ou Asset Management Co., Ltd
1.066 %
4,290,024 1.066 % 27 M ¥
Bosera Asset Management Co., Ltd.
0.6907 %
2,780,480 0.6907 % 17 M ¥
OrbiMed Advisors Private Equity
0.6035 %
2,429,200 0.6035 % 15 M ¥
JPMorgan Investment Management, Inc.
0.4958 %
1,995,747 0.4958 % 12 M ¥
Essence Fund Co., Ltd.
0.4944 %
1,990,000 0.4944 % 12 M ¥
BlackRock (Netherlands) BV
0.4634 %
1,865,520 0.4634 % 12 M ¥
NameEquities%Valuation
Ge Li
23.19 %
593,458,536 23.19 % 4 495 M ¥
Temasek Holdings Pte Ltd. (Investment Management)
4.492 %
114,982,796 4.492 % 871 M ¥
Shanghai Zhongmin Yinfu Capital Management Co. Ltd.
3.402 %
87,074,568 3.402 % 659 M ¥
Zhong Ou Asset Management Co., Ltd
3.359 %
85,972,176 3.359 % 651 M ¥
Bank of Communications Schroder Fund Management Co., Ltd.
2.508 %
64,186,808 2.508 % 486 M ¥
Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt)
2.185 %
55,929,182 2.185 % 424 M ¥
ICBC Credit Suisse Asset Management Co., Ltd.
1.680 %
42,996,043 1.680 % 326 M ¥
Hwabao WP Fund Management Co., Ltd.
1.454 %
37,204,598 1.454 % 282 M ¥
China Merchants Fund Management Co., Ltd.
1.159 %
29,663,715 1.159 % 225 M ¥
29,361,931 1.147 % 222 M ¥
NameEquities%Valuation
HSBC Global Asset Management (Hong Kong) Ltd.
42.20 %
88,348 42.20 % 669 127 ¥

Holdings

NameEquities%Valuation
600,000,000 50.10% 1,394,850,000 $
8,180,678 3.25% 23,887,580 $
4,225,696 9.71% 13,522,227 $
5,249,608 1.90% 5,169,604 $
194,139 0.75% 159,388 $
6,636 0.02% 119,846 $

Company contact information

WuXi AppTec Co., Ltd.

288 Fute Middle Road Waigaoqiao Free Trade Zone

200131, Shanghai

+86 21 5046 1111

http://www.wuxiapptec.com.cn
address WuXi AppTec Co., Ltd.(603259)

Group companies

NameCategory and Sector
Pharmaceuticals: Major